Adial Pharmaceuticals, Inc. Current Liabilities
Adial Pharmaceuticals, Inc. (ADIL) had Current Liabilities of $5.12 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $5.12M.
- 2026-03-31: Liabilities, Current $1.51M.
- 2025-12-31: Liabilities, Current $1.40M; Liabilities, Current as first filed $1.40M.
- 2025-09-30: Liabilities, Current $1.15M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.12M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.51M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $1.40M 10-Q · filed 2026-08-14 | $1.40M 10-K · filed 2026-03-05 |
| 2025-09-30 | $1.15M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.21M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.32M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $975.86K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $829.05K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $671.88K 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $653.08K 10-K · filed 2025-03-04 | |
| 2023-09-30 | $528.18K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $461.75K 10-Q/A · filed 2023-10-30 | |
| 2023-03-31 | $1.80M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.79M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $1.33M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.87M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $2.17M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $2.72M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $1.96M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.21M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $2.04M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.51M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $1.09M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $681.89K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $389.83K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $539.05K 10-K · filed 2021-03-22 | |
| 2019-09-30 | $776.95K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $626.55K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $329.19K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $257.97K 10-K · filed 2020-03-20 | |
| 2018-09-30 | $322.81K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $1.48M 10-Q · filed 2018-09-10 | |
| 2017-12-31 | $1.03M 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |